agenda items (7)

Join us at the end of spring for an informal get-together, where you can meet long-known and new peers over some good food and drinks.

Don't miss the keynote by Thierry Geerts, Country Director at Google Belgium, on his book 'Homo Digitalis' and his view on the impact of digital revolution on healthcare! Every participant receives a copy of his book.

About Healixia

Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

Healixia events

  1. online.jpg
    03 June '22

    Webinar: IB for an early phase/FIH trial: more than just a regulatory document

    This online workshop will discuss the IB structure, content and quality as important topics for all parties involved in planning, set-up, conduct and interpretation of a clinical study. Some practical highlights will be shared on challenges on writing a “good” IB for a FIH/Early Phase trial on the one hand, and on how to use it for an optimal benefit-risk assessment on the other hand. 

  2. j-kelly-brito-PeUJyoylfe4-unsplash.jpg
    09 September '22

    Webinar: How to use the IB in de-risking FiH study

    Online

    More information will follow soon!

Show all meetings

News

  1. May 24, 2022

    Coronavirus: the Belgian guideline for the management of clinical trials during the coronavirus pandemic no longer applies

    Due to the ending of the epidemiological emergency situation on 10 March 2022, the Belgian guideline to assist sponsors in the management of clinical trials during the coronavirus pandemic no longer applies. From now on, the rules in force will be applied and any deviation must be requested by providing a clear description of the situation. 

    Source: FAMHP

    Read more

  2. May 18, 2022

    New antimicrobial drugs available in Belgium: Colistineb, Zerbaxa, Broxil and Rukobia. Important for patients and for the fight against antimicrobial resistance.

    De beschikbaarheid van geschikte antimicrobiële middelen zorgt ervoor dat artsen meer mogelijkheden hebben om de beste behandeling te voorzien voor hun patiënten. Het is ook belangrijk in de strijd tegen antimicrobiële resistentie. Colistineb, Zerbaxa, Broxil en Rukobia zijn  antimicrobiële geneesmiddelen die recent beschikbaar werden in België.

    La disponibilité des médicaments antimicrobiens appropriés donne aux médecins davantage de possibilités de fournir le meilleur traitement à leurs patients. Elle est également importante dans la lutte contre la résistance aux antimicrobiens. Colistineb, Zerbaxa, Broxil et Rukobia sont des médicaments antimicrobiens qui ont récemment été mis sur le marché en Belgique.

    Source: FAMHP

    Read more

  3. May 17, 2022

    Call for tender by the European Commission: reservation of manufacturing capacities and priority right to manufacture vaccines

    The European Commission has launched a call for tender to conclude single (consortium) framework contracts to reserve manufacturing capacities and obtain a priority right to manufacture vaccines in case of a future public health emergency. The project is called EU FAB.

    Source: FAMHP

    Read more

We thank our partners for their support. Click on the logos for more information:
 
digidyco_clinical esolutions_gr_web2.png QbD_logo_RGB_300dpi logo Hebias web.png Modis 440x320 nieuwsbrief.jpg
jsn_logo_jj_vert_color_rgb.jpg AxTalis_reg access medical_scherm_white SCIENCETALENTS_LOGO_RGB_POS.png Brookwood Global-website.png